Our team includes seasoned industry experts and career consultants with an extensive array of skills and experience.
Sam Malik
Managing Partner
Sam has over 25 years of experience in the pharmaceutical industry and in consulting. His expertise includes healthcare policy, pharmaceutical marketing, pricing, business strategy and organizational design. He has been closely involved in developing launch and market entry strategies for new injectable biologics and rare therapies.As EVP of Managed Markets at inVentiv Advance Insights, Sam led the managed markets consulting team. Prior to this he co-founded and led Strategyx, building a consulting group of the best and brightest professionals from the pharmaceutical, biotechnology and management consulting industries. Strategyx was acquired by inVentiv Health in 2007. Before Strategyx, he held senior positions in product marketing, market research, account management, pricing and business development. Sam holds an MBA from Dartmouth College.
Managing Partner
Sam has over 25 years of experience in the pharmaceutical industry and in consulting. His expertise includes healthcare policy, pharmaceutical marketing, pricing, business strategy and organizational design. He has been closely involved in developing launch and market entry strategies for new injectable biologics and rare therapies.As EVP of Managed Markets at inVentiv Advance Insights, Sam led the managed markets consulting team. Prior to this he co-founded and led Strategyx, building a consulting group of the best and brightest professionals from the pharmaceutical, biotechnology and management consulting industries. Strategyx was acquired by inVentiv Health in 2007. Before Strategyx, he held senior positions in product marketing, market research, account management, pricing and business development. Sam holds an MBA from Dartmouth College.
Cheryl Del Rosario
Partner
Cheryl has worked in the pharmaceutical industry for over ten years. Her most recent experience includes strategic planning and brand building for chronic and specialty medications. Her expertise includes the US, Canada and the EU.As Director for Advance Insights, Cheryl created strategies for a broad range of biotech and pharmaceutical products, including pre-launch planning, market entry, channel, contracting, and pricing. As market research director for OBIS, a market research and consulting firm dedicated to oncology, she developed a team that designed and analyzed market intelligence using both primary and secondary sources to assess market opportunities and track trends in the oncology market. Cheryl holds an MBA from New York University, Stern School of Business
Partner
Cheryl has worked in the pharmaceutical industry for over ten years. Her most recent experience includes strategic planning and brand building for chronic and specialty medications. Her expertise includes the US, Canada and the EU.As Director for Advance Insights, Cheryl created strategies for a broad range of biotech and pharmaceutical products, including pre-launch planning, market entry, channel, contracting, and pricing. As market research director for OBIS, a market research and consulting firm dedicated to oncology, she developed a team that designed and analyzed market intelligence using both primary and secondary sources to assess market opportunities and track trends in the oncology market. Cheryl holds an MBA from New York University, Stern School of Business
Karen O’Neal
Vice President
Karen has 30 years of experience providing pharmaceutical marketing and sales executives with various commercialization resources and strategies to support product life cycle management. While at inVentiv Health, she worked with leadership teams to optimize direct and non-personal promotional resources in support of product and portfolio success. Karen has worked extensively on managed markets consulting engagements including landscape assessments, value messaging and launch planning. Most recently, she worked to develop pricing and contracting strategies for physician administered biologics. Her therapeutic category knowledge extends across a broad range of cardiovascular, oncology, neurology and respiratory products.Prior to joining Percipient, Karen held line and management positions with inVentiv Health, Strategyx and IMS Health.Karen holds an MBA from New York University and a BA from Harvard University.
Vice President
Karen has 30 years of experience providing pharmaceutical marketing and sales executives with various commercialization resources and strategies to support product life cycle management. While at inVentiv Health, she worked with leadership teams to optimize direct and non-personal promotional resources in support of product and portfolio success. Karen has worked extensively on managed markets consulting engagements including landscape assessments, value messaging and launch planning. Most recently, she worked to develop pricing and contracting strategies for physician administered biologics. Her therapeutic category knowledge extends across a broad range of cardiovascular, oncology, neurology and respiratory products.Prior to joining Percipient, Karen held line and management positions with inVentiv Health, Strategyx and IMS Health.Karen holds an MBA from New York University and a BA from Harvard University.